Pharmaceutical and Life Sciences Companies Look to a More Holistic Approach to Enterprise-Wide Content Management



    A Centralized View of Business Content Helps to Preserve and Protect
    Intellectual Capital and Mitigate Risk and Corporate Liability

    DIA 43rd Annual Meeting, ATLANTA, GA, June 19 /CNW/ - Facing increased
regulatory and legal scrutiny, pharmaceutical and life sciences companies have
rushed to adopt new technology to cope. But the rapid pace of adoption has
left many companies juggling a hodge-podge of information silos. Their biggest
challenge today is taking an enterprise wide approach to managing enterprise
content that ensures consistency, speeds product development and reduces
costs.
    According to Open Text(TM) Corporation (NASDAQ:   OTEX, TSX: OTC), a
leading provider of Enterprise Content Management (ECM) software, life
sciences industry companies need to create an enterprise-wide content
management strategy to consolidate content-centric applications, and provide a
holistic, centralized view of business content across all systems,
repositories and geographies.
    In the pharmaceutical industry, accurate and reliable documentation is
essential to show that critical processes that could impact human health, such
as the manufacture of a drug, have been performed to industry standards.
Sharing key information with team members, making the best decisions possible
based on all relevant information, and complying with regulatory requirements
are crucial. An enterprise-wide content management strategy improves
information sharing across departments and supports critical processes for the
compliant management of all paper and electronic records and documents.
    "Because life sciences companies deal with human health and the safety of
new drugs and devices, the information management stakes are very high," said
Brett Shellhammer, Vice President of Business Solutions for Open Text.
"Creating enterprise transparency is a major challenge as the product
development stages become segmented between departments and content does not
transition efficiently through the phases of the drug lifecycle. Inconsistent
processes can lead to not only serious impacts to project timelines and
schedules but also significant legal and regulatory compliance risks. By
implementing an enterprise content management system, life sciences companies
can ensure that all vital information is secured and centrally managed,
increasing operational efficiencies and mitigating risk."
    In addition to the benefits of information sharing and reduced
duplication of efforts, life sciences companies are recognizing the pure cost
advantage of a single ECM system for the housing of all vital business
information. By deploying a single ECM platform for the management of finance
and operational content, drug development documents, clinical trials and
patient record information, Standard Operating Procedures (SOP), and quality
control documents, companies can lower the total-cost-of-ownership of content
management technology, and significantly reduce the roll-out and training
investment associated with the deployment of a new desktop application.
    Life sciences companies can take several steps to ensure they're on the
right path to achieving enterprise transparency by leveraging existing
technology solutions and content repositories and coupling them with a
next-generation enterprise content management framework. Powerful enterprise
search functions, security controls to ensure appropriate access, metadata
capture, secure information retrieval with process automation tools, and
intuitive retrieval capabilities are all required to ensure content is
available to appropriate users when they need it and in the context of how
they are working with that content.
    Open Text recognizes the emerging industry need to have enterprise
transparency and an enterprise-wide content management strategy in life
sciences. With Open Text's ECM solutions and applications for life sciences
companies, customers can more effectively leverage content and metadata
investments across applications and the organization, to provide a unified
view of business content for risk mitigation, compliance with regulatory
requirements, as well as significant productivity gains and better
decision-making.
    "Life sciences companies look to Open Text, not only for the latest
software solutions, but also for people who truly understand their complex
business requirements as it relates to content management, security, and
solutions for regulatory content and submissions management, quality
management, and clinical trials procedures," added Shellhammer. "We possess
the domain expertise, re-usable best practices, and a strong network of
partners that work closely with us to develop and extend the value of our
offerings for pharmaceutical and life sciences companies."

    Open Text will be showcasing its industry-specific solutions for
pharmaceutical and life sciences companies at DIA's 43rd Annual Meeting
(www.diahome.org/DIAHome/FlagshipMeetings/home.aspx?meetingid=11362) being
held this week in Atlanta, Georgia, at the Georgia World Congress Center. Open
Text will be at booth No. 115.

    Detailed information about Open Text's life sciences solutions can be
found at http://www.opentext.com/2/sol-industry/sol-ind-pharma.htm

    About Open Text

    Open Text(TM) is the world's largest independent provider of Enterprise
Content Management software. The company's solutions manage information for
all types of business, compliance and industry requirements in the world's
largest companies, government agencies and professional service firms.
Open Text supports approximately 46,000 customers and millions of users in 114
countries and 12 languages. For more information about Open Text, visit
www.opentext.com.

    Safe Harbor Statement Under the Private Securities Litigation Reform Act
    of 1995

    This news release may contain forward-looking statements relating to the
success of any of the Company's strategic initiatives, the Company's growth
and profitability prospects, the benefits of the Company's products to be
realized by customers, the Company's position in the market and future
opportunities therein, the deployment of Livelink and our other products by
customers, and future performance of Open Text Corporation. Forward-looking
statements may also include, without limitation, any statement relating to
future events, conditions or circumstances. Forward-looking statements in this
release are not promises or guarantees and are subject to certain risks and
uncertainties, and actual results may differ materially. The risks and
uncertainties that may affect forward-looking statements include, among
others, the failure to develop new products, risks involved in fluctuations in
currency exchange rates, delays in purchasing decisions of customers, the
completion and integration of acquisitions, the possibility of technical,
logistical or planning issues in connection with deployments, the continuous
commitment of the Company's customers, demand for the Company's products and
other risks detailed from time to time in the Company's filings with the
Securities and Exchange Commission (SEC), including the Form 10-K for the year
ended June 30, 2006. You should not place undue reliance upon any such
forward-looking statements, which are based on management's beliefs and
opinions at the time the statements are made, and the Company does not
undertake any obligations to update forward-looking statements should
circumstances or management's beliefs or opinions change.

    Copyright (C) 2007 by Open Text Corporation. LIVELINK and OPEN TEXT are
    trademarks or registered trademarks of Open Text Corporation in the
    United States of America, Canada, the European Union and/or other
    countries. This list of trademarks is not exhaustive. Other trademarks,
    registered trademarks, product names, company names, brands and service
    names mentioned herein are property of Open Text Corporation or other
    respective owners.





For further information:

For further information: Rich Maganini, Open Text Corporation, (847)
267-9330, x4266, rmaganin@opentext.com; Michele Stevenson, Open Text
Corporation, (519) 888-7111, x2594, mstevens@opentext.com; Brian Edwards,
McKenzie Worldwide, (503) 577-4583, briane@mckenzieworldwide.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890